Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Evolus Inc (EOLS)

  • Event
  • Aug. 02, 2022, 12:29 UTC
  • 14
  • 1 comments

(30% Negative) EVOLUS, INC. (EOLS) Reports Q3 2022 Financial Results

Comment Full text

Phathom Pharmaceuticals Inc (PHAT)

  • Event
  • Aug. 02, 2022, 12:25 UTC
  • 14
  • 1 comments

(19% Negative) PHATHOM PHARMACEUTICALS, INC. (PHAT) Reports Q3 2022 Financial Results

Comment Full text

Blueprint Medicines Corp (BPMC)

  • Event
  • Aug. 02, 2022, 11:47 UTC
  • 14
  • 1 comments

(10% Negative) Blueprint Medicines Corporation (BPMC) Reports Q3 2022 Financial Results

Comment Full text

Harmony Biosciences (HRMY)

  • Event
  • Aug. 02, 2022, 11:45 UTC
  • 14
  • 1 comments

(10% Negative) HARMONY BIOSCIENCES HOLDINGS, INC. (HRMY) Reports Q3 2022 Financial Results

Comment Full text

Incyte Corporation (INCY)

  • Event
  • Aug. 02, 2022, 11:25 UTC
  • 14
  • 1 comments

(30% Negative) INCYTE CORPORATION (INCY) Reports Q3 2022 Financial Results

Comment Full text

Esperion Therapeutics Inc (ESPR)

  • Event
  • Aug. 02, 2022, 11:24 UTC
  • 14
  • 1 comments

(30% Negative) Esperion Therapeutics, Inc. (ESPR) Reports Q3 2022 Financial Results

Comment Full text

Tonix Pharmaceuticals Holding Corp (TNXP)

  • Event
  • Aug. 02, 2022, 11:07 UTC
  • 13
  • 1 comments

(99% Neutral) TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) Announces Clinical Development Update

Comment Full text

Rhythm Pharmaceuticals Inc (RYTM)

  • Event
  • Aug. 02, 2022, 11:02 UTC
  • 14
  • 1 comments

(30% Negative) RHYTHM PHARMACEUTICALS, INC. (RYTM) Reports Q3 2022 Financial Results

Comment Full text

Sage Therapeutics Inc (SAGE)

  • Event
  • Aug. 02, 2022, 10:45 UTC
  • 14
  • 1 comments

(10% Negative) Sage Therapeutics, Inc. (SAGE) Reports Q3 2022 Financial Results

Comment Full text

Gracell Biotechnologies Inc (was acquired by AstraZeneca (NASDAQ: AZN) on 20/02/2024)) (GRCL)

  • Event
  • Aug. 02, 2022, 10:10 UTC
  • 11
  • 1 comments

(90% Positive) Gracell Biotechnologies Inc (was acquired by AstraZeneca (NASDAQ: AZN) on 20/02/2024)) (GRCL) Announces Clinical Development Update (Form 6-K)

Comment Full text
  • Previous
  • 143
  • 144
  • 145
  • 146
  • 147
  • Next

Search

News categories

  • Technical Exchange News(10877)
  • Event(2261)
  • SEC News(189391)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124578)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin